Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report) rose 1.1% on Thursday. The stock traded as high as $1.87 and last traded at $1.87. Approximately 350 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 3,560 shares. The stock had previously closed at $1.85.
Mayne Pharma Group Stock Performance
The business has a fifty day moving average of $2.05 and a 200-day moving average of $1.89.
About Mayne Pharma Group
Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company that develops, manufactures, and commercializes branded and generic prescription medicines. Its activities include product development, regulatory support, manufacturing, and the distribution of pharmaceutical products through its own commercial operations and external partners.
The company has focused on therapeutic areas including dermatology, women’s health, and other specialty-care markets. Its portfolio has included prescription products such as oral and topical medicines, as well as contraceptive and other branded therapies.
Recommended Stories
- Five stocks we like better than Mayne Pharma Group
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
